Full Product Name
CYBB Antibody - C-terminal region
Product Gene Name
anti-CYBB antibody
[Similar Products]
Product Synonym Gene Name
AMCBX2; CGD; GP91-1; GP91-PHOX; GP91PHOX; NOX2; p91-PHOX[Similar Products]
Antibody/Peptide Pairs
CYBB peptide (MBS3243530) is used for blocking the activity of CYBB antibody (MBS3218637)
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Immunogen Sequence
Synthetic peptide located within the following region: GRPNWDNEFK TIASQHPNTR IGVFLCGPEA LAETLSKQSI SNSESGPRGV
3D Structure
ModBase 3D Structure for P04839
Species Reactivity
Cow, Dog, Guinea Pig, Horse, Human, Mouse, Rabbit, Rat
Purity/Purification
Affinity Purified
Form/Format
Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.
Homology
Cow: 85%; Dog: 93%; Guinea Pig: 77%; Horse: 86%; Human: 100%; Mouse: 100%; Rabbit: 100%; Rat: 100%
Immunogen
The immunogen is a synthetic peptide directed towards the C-terminal region of Human CYBB
Preparation and Storage
For short term use, store at 2-8 degree C up to 1 week. For long term storage, store at -20 degree C in small aliquots to prevent freeze-thaw cycles.
Other Notes
Small volumes of anti-CYBB antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
anti-CYBB antibody
This is a rabbit polyclonal antibody against CYBB. It was validated on Western Blot
Target Description: Cytochrome b (-245) is composed of cytochrome b alpha (CYBA) and beta (CYBB) chain. It has been proposed as a primary component of the microbicidal oxidase system of phagocytes. CYBB deficiency is one of five described biochemical defects associated with chronic granulomatous disease (CGD). In this disorder, there is decreased activity of phagocyte NADPH oxidase; neutrophils are able to phagocytize bacteria but cannot kill them in the phagocytic vacuoles. The cause of the killing defect is an inability to increase the cell's respiration and consequent failure to deliver activated oxygen into the phagocytic vacuole.
Product Categories/Family for anti-CYBB antibody
Polyclonal; Signal Proteins; Lymphocyte Signaling; Membrane Protein; Cell Biology; Mitochondria; Membrane & Traffic; Disease Related;
Applications Tested/Suitable for anti-CYBB antibody
Western Blot (WB)
Western Blot (WB) of anti-CYBB antibody
Host: Rabbit
Target Name: CY24B
Sample Type: 721_B Whole Cell lysates
Antibody Dilution: 1.0ug/ml

Western Blot (WB) of anti-CYBB antibody
Host: Rabbit
Target Name: CY24B
Sample Type: 721_B Whole Cell lysates
Antibody Dilution: 1ug/ml

Western Blot (WB) of anti-CYBB antibody
Host: Rabbit
Target Name: CYBB
Sample Tissue: Human Jurkat
Antibody Dilution: 1.0ug/ml

Western Blot (WB) of anti-CYBB antibody
Host: Rabbit
Target Name: CYBB
Sample Type: 721_B Whole Cell lysates
Antibody Dilution: 1.0ug/ml

NCBI/Uniprot data below describe general gene information for CYBB. It may not necessarily be applicable to this product.
NCBI Accession #
NP_000388
[Other Products]
NCBI GenBank Nucleotide #
NM_000397
[Other Products]
UniProt Primary Accession #
P04839
[Other Products]
UniProt Related Accession #
P04839[Other Products]
NCBI Official Full Name
cytochrome b-245 heavy chain
NCBI Official Synonym Full Names
cytochrome b-245 beta chain
NCBI Official Symbol
CYBB??[Similar Products]
NCBI Official Synonym Symbols
CGD; NOX2; IMD34; AMCBX2; GP91-1; GP91PHOX; p91-PHOX; GP91-PHOX
??[Similar Products]
NCBI Protein Information
cytochrome b-245 heavy chain
UniProt Protein Name
Cytochrome b-245 heavy chain
UniProt Synonym Protein Names
CGD91-phox; Cytochrome b(558) subunit beta; Cytochrome b558 subunit beta; Heme-binding membrane glycoprotein gp91phox; NADPH oxidase 2; Neutrophil cytochrome b 91 kDa polypeptide; Superoxide-generating NADPH oxidase heavy chain subunit; gp91-1; gp91-phox; p22 phagocyte B-cytochrome
Protein Family
Cytochrome
UniProt Gene Name
CYBB??[Similar Products]
UniProt Synonym Gene Names
NOX2; Cytochrome b558 subunit beta??[Similar Products]
UniProt Entry Name
CY24B_HUMAN
NCBI Summary for CYBB
Cytochrome b (-245) is composed of cytochrome b alpha (CYBA) and beta (CYBB) chain. It has been proposed as a primary component of the microbicidal oxidase system of phagocytes. CYBB deficiency is one of five described biochemical defects associated with chronic granulomatous disease (CGD). In this disorder, there is decreased activity of phagocyte NADPH oxidase; neutrophils are able to phagocytize bacteria but cannot kill them in the phagocytic vacuoles. The cause of the killing defect is an inability to increase the cell's respiration and consequent failure to deliver activated oxygen into the phagocytic vacuole. [provided by RefSeq, Jul 2008]
UniProt Comments for CYBB
CYBB: Critical component of the membrane-bound oxidase of phagocytes that generates superoxide. It is the terminal component of a respiratory chain that transfers single electrons from cytoplasmic NADPH across the plasma membrane to molecular oxygen on the exterior. Also functions as a voltage-gated proton channel that mediates the H(+) currents of resting phagocytes. It participates in the regulation of cellular pH and is blocked by zinc. Defects in CYBB are a cause of granulomatous disease,chronic, X-linked (CGD). A disorder characterized by the inability of neutrophils and phagocytes to kill microbes that they have ingested. Patients suffer from life- threatening bacterial/fungal infections. Defects in CYBB are a cause of mycobacteriosis atypical X-linked type 2 (AMCBX2). A rare condition characterized by predisposition to illness caused by moderately virulent mycobacterial species, such as Bacillus Calmette-Guerin (BCG) vaccine and environmental non-tuberculous mycobacteria, and by the more virulent Mycobacterium tuberculosis. Other microorganisms rarely cause severe clinical disease in individuals with susceptibility to mycobacterial infections.
Protein type: Oxidoreductase; Mitochondrial; EC 1.-.-.-; Membrane protein, integral; Membrane protein, multi-pass
Chromosomal Location of Human Ortholog: Xp21.1
Cellular Component: Golgi apparatus; phagocytic vesicle membrane; rough endoplasmic reticulum; cell soma; mitochondrion; integral to plasma membrane; dendrite; plasma membrane; NADPH oxidase complex
Molecular Function: protein binding; FAD binding; electron carrier activity; protein heterodimerization activity; metal ion binding; superoxide-generating NADPH oxidase activity; heme binding; voltage-gated ion channel activity
Biological Process: response to drug; respiratory burst; interaction with host; superoxide metabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; antigen processing and presentation of peptide antigen via MHC class I; innate immune response; antigen processing and presentation of exogenous peptide antigen via MHC class I; ion transport; vascular endothelial growth factor receptor signaling pathway; inflammatory response; superoxide release; hydrogen peroxide biosynthetic process; response to nutrient
Disease: Immunodeficiency 34; Granulomatous Disease, Chronic, X-linked
Research Articles on CYBB
1. We describe a 17-year old girl with X-linked chronic granulomatous disease caused by the expression of a heterozygous frameshift mutation in the CYBB gene at Xp21.1 causing a premature stop codon in exon 9 of the complementary DNA, leading to a truncated gp91phox protein due to skewed inactivation of the normal X chromosome. To our knowledge, this is the first report of a patient carrying this mutation in the CYBB gene.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.